Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device for cancer and life-threatening viral infections and use in organ transplantation. The company was founded in 1984 and is based in San Diego, California.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [07/02/2025 08:07 PDT] AEMD Expected to Trade Down After Bearish Patterns Develop
• [06/27/2025 21:21 PDT] Market Maker Surveillance Report. AEMD, Losing Stocks With Lowest Price Friction For Friday, June 27th 2025
• [06/13/2025 10:29 PDT] Aethlon Medical, Inc. (NASDAQ:AEMD), Down By 100% ($2.35) From $2.35 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [06/10/2025 06:55 PDT] AEMD Expected to Trade Down After Bearish Patterns Develop
• [05/15/2025 06:53 PDT] AEMD Expected to Trade Up After Bullish Patterns Develop